Trades on 1 secondary market

Curiebio

Curie.Bio is a seed-stage biotech venture firm and drug-discovery co-pilot co-founded by Zach Weinberg (founder of Flatiron Health), Alexis Borisy, and Christoph Lengauer. It pairs seed investment — typically $5M-$7M initial checks, backed by a $380M pro-rata Series A follow-on fund — with hands-on

minimal 14.6 / 100 0 APIs View provider profile →

Company Venture Capital Biotechnology Life Sciences Drug Discovery Therapeutics

Curiebio is an API provider whose private shares are listed on 1 secondary market: EquityZen.

Where It Trades

EZ EquityZen View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.